Myriad Genetics公司发现了乳腺癌和卵巢癌BRCA1和BRCA2基因，他们有资金的乳腺癌和卵巢癌有关的基因，然后成为公共利益的基因。世界各地的人都可以访问的基因。美国公民自由联盟（ACLU）和基因技术有限公司澳大利亚为宗旨，以创造出一种新产品针对的乳腺癌和卵巢癌，但它的商业目标，目标仍然是做测试在发展中，更多的测试仍然是必要的。 BRCA1和BRCA2是不能被授予专利，Myriad Genetics公司是不能够从基因来获取利润。美国公民自由联盟（ACLU）和基因技术有限公司澳大利亚的创新和，只要他们成功创建的产品，他们可以申请专利和获得的利润回报。
我原来的观点是这些公司使用的公众发现的其他实体，应给予一些回报，但它只是从道德的观点，没有。 Myriad Genetics公司不应该只集中在人类基因组的发现，但也需要付出一点点关注如何转换的发现转化为现实的作品，这样来获取利润。 Myriad Genetics公司的基因，他们的优势在于给其他实体，如果他们可以使用，使产品的基因，这一发现将成为创新，那么他们可以申请专利，并使其成为竞争对手的产品不只是公共物品。同时，建议可以到的人谁发现的新基因，奖励他们提出，从社会，从基金或利润的好处可以产生一定的奖励。也可以给的昵称根的人发现它，这样可以鼓励遗传学家做出更好的贡献。
The Myriad Genetics discovered the breast and ovarian cancer genes BRCA1 and BRCA2, they have fund the genes are relevant to the breast and ovarian cancer, and then the genes are become public good. People all over the world can get access to the genes. The American Civil Liberties Union (ACLU) and the Genetic Technologies Limited Australia are doing the test for the purpose to create a kind of new products which in allusion to the breast and ovarian cancers, although it is for the commercial objective, the objective is still under developing, more tests are still necessary. The BRCA1 and BRCA2 are not patentable; Myriad Genetics is not able to obtain profits from the genes. The American Civil Liberties Union (ACLU) and the Genetic Technologies Limited Australia are making an innovation and as soon as they succussed creating the products they can apply the patent and obtain the profits in return.
My original point is those companies use the public which discovered by other entities, should give something in return, but it is only from the view of ethical, do not have to. The Myriad Genetics should not only concentrate on the discovery of human genome, but also need to pay a little bit attention of how to convert discoveries into real productions so that to obtain profits. Myriad Genetics found the genes, they have the advantage to other entities, if they can use the genes to make products, the discovery will become innovation and then they can apply the patent and make it become rival goods not just public goods. Meanwhile it suggested that some reward can be made to the people who discovery new gene, the reward can be generated from the fund they raise from society, or the profit from the benefits. Can also give nick name to the gen by the person who discovery it, so that can encourage geneticist to make better contributions.